精神障碍诊断与统计手册（第五版-修订版）（DSM-5-TR）

美国精神医学学会于2013年5月推出了美国精神障碍分类与诊断标准的最新版本——《精神障碍诊断与统计手册（第五版）》（DSM-5）。DSM被誉为精神障碍领域的\"圣经\"，是一本美国及其他国家常用的诊断精神障碍的指导手册。为了能进一步改进精神疾病的诊断、治疗、科研和在所有临床工作者中产生一种共同语言，DSM-5对所有精神疾病进行了重新定义和分类，并制订了精确和具体的诊断标准，因而极具实用价值。 本书（DSM-5-TR）是DSM-5的文本修订版。该版本对DSM-5的绝大多数障碍的文本进行了修订，更新了相关特征、患病率、发展与病程、风险与预后因素、与文化相关的诊断问题、诊断标志物、与自杀想法或行为的相关性、鉴别诊断等内容；增加了“延长哀伤障碍”的诊断；将最初发布的 DSM-5 诊断标准与对 70 多种障碍的修改（大部分做了澄清）相整合；全面更新了“介绍”和“使用手册”部分，并为重要术语提供上下文背景，以指导临床工作者使用；采用了更新的ICD-10-CM编码，并新增了50多个有关物质中毒、物质戒断和其他障碍的编码。 DSM-5-TR是精神卫生临床工作者和研究人员不可或缺的临床实践资源，对于精神障碍的诊断具有重要的指导意义。期盼DSM-5-TR中文版的问世，为国内广大相关专业人员提供极具价值的参考和借鉴。

美国精神医学学会（American Psychiatric Association, APA） ，美国精神科医生的专业组织，在行业内具有全球性的影响力。现有约38000名会员，大部分在美国。其出版物除学术期刊及小册子以外，最为人熟悉的就是《精神障碍诊断与统计手册》，简称“DSM”。这本手册是美国主要诊断精神障碍的重要标准，也是全世界许多国家在诊断精神障碍上的重要参考。 【美国】张道龙 ---------------------------- 张道龙，毕业于哈尔滨医科大学并完成神经病学住院医师培训，中国大陆首位毕业于美国芝加哥大学精神医学系的精神科医生，河北医科大学、齐齐哈尔医学院等国内医学院客座教授。现就职于美国帕洛阿托退伍军人医学中心(斯坦福大学教学医院)，珠海市第三人民医院国际精神心理服务部首席专家。深耕精神心理30余年，亲自诊治中美来访者及患者超过20万人次，曾获得美国精神医学学会促进少数族裔精神健康奖;北美华人医师联盟 2017年度、2018年、2022年“医学教育奖”，第一位将美式 EAP 员工帮助计划、SAP学生帮助计划引进中国的专家，历时10余年翻译、编写完成12本教材

目　　录 第一部分 DSM-5 基础 介绍································································································································5 使用手册 ·······················································································································21 DSM-5 司法谨慎使用声明 ···························································································29 第二部分 诊断标准与编码 神经发育障碍 ···············································································································35 精神分裂症谱系及其他精神病性障碍 ··········································································97 双相及相关障碍 ·········································································································135 抑郁障碍 ····················································································································· 171 焦虑障碍 ····················································································································· 209 强迫及相关障碍 ········································································································ 257 创伤及应激相关障碍 ··································································································289 分离障碍 ····················································································································· 323 躯体症状及相关障碍 ··································································································343 喂食及进食障碍 ·········································································································365 排泄障碍 ····················································································································· 391 睡眠-?觉醒障碍 ··········································································································399 性功能失调 ················································································································· 469 性别烦躁 ····················································································································· 501 破坏性、冲动控制及品行障碍 ··················································································· 511 精神障碍诊断与统计手册（第五版-修订版）（DSM-5-TR） 物质相关及成瘾障碍 ··································································································533 神经认知障碍 ············································································································· 657 人格障碍 ····················································································································· 721 性欲倒错障碍 ············································································································· 765 其他精神障碍和额外编码 ··························································································789 药物所致的运动障碍及其他药物不良反应 ································································793 可能成为临床关注焦点的其他状况 ···········································································807 第三部分 新出现的量表和模式 评估量表 ··························································································